2:00 – 5:00 PM

SC1: Translating CTCs and ctDNA for Clinical Use

Dana W.Y. Tsui, Ph.D., Assistant Attending Geneticist; Member, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center

Emmanuel Antonarakis, M.D., Associate Professor, Urologic Oncology, Johns Hopkins University

Sonya Parpart-Li, Ph.D., Team Lead, Product Development, Personal Genome Diagnostics

SC2: NGS Assay Selection, Validation and Compliance

Maria E. Arcila, M.D., Pathologist and Director, Diagnostic Molecular Pathology Laboratory, Memorial Sloan Kettering Cancer Center (AMP Member)

Eric Duncavage, M.D., Assistant Professor, Pathology & Immunology, Washington University School of Medicine (AMP Hematopathology Subdivision Representative to the AMP 2018 Program Committee; Member)

Birgit Funke, Ph.D., FACMG, Vice President, Clinical Affairs, Veritas Genetics; Associate Professor of Pathology, Harvard Medical School (AMP Genetics Subdivision Chair and Representative to the AMP 2018 Board of Directors; Member)

SC3: Sequencing 101

Ryan Kim, Ph.D., President & CEO, Macrogen USA

SC4: Omic Technology for Cancer Immunotherapy

James Robert White, Ph.D., Founder, Resphera Biosciences

Xing Wang, Ph.D., President, R&D, Array Bridge Inc

Lauren Ritterhouse, M.D., PH.D., Assistant Professor of Pathology, Genomic and Molecular Pathology Division The University of Chicago Medicine & Biological Sciences

SC5: Coverage and Reimbursement for Advanced Diagnostics

Kurt Matthes, Vice President, RCM Reengineering and Service, Revenue Cycle Management, TELCOR, Inc.

Girish Putcha, M.D., Ph.D., Director of Laboratory Science, MolDx, Palmetto GBA

Becky Foster, Principal , Foster Health Care Consulting

SC6: Innovative Imaging Technologies for Patient CTCs

Stuart S. Martin, Ph.D., Professor of Physiology, Greenebaum NCI Comprehensive Cancer Center, University of Maryland School of Medicine

SC7: Precision Medicine 101

Jeanette McCarthy, MPH, Ph.D., Adjunct Associate Professor, Duke University; Founder, Precision Medicine Advisors

5:30 – 8:30 PM

SC9: Clinical Informatics: Returning Results from Big Data

N. Sertac Kip, M.D., Ph.D., Director, Oncology, Mount Sinai Hospital (AMP Member)

Mark Routbort, M.D., Ph.D., Director, Computational and Integrational Pathology; Associate Professor, Hematopathology; Medical Director, Laboratory Informatics, UT MD Anderson Cancer Center (AMP Informatics Subdivision Representative to the AMP 2017 Clinical Practice Committee; Member)

Stephen E. Lincoln, Senior Vice President, InVitae (AMP NGS Bioinformatics Pipeline Validation Working Group; Member)

SC10: Regulatory Compliance in Molecular Diagnostics

Melina Cimler, Ph.D., Senior Vice President, Quality & Regulatory, Adaptive Biotechnologies

Pamela L. Swatkowski, Director, Regulatory Affairs, Abbott Molecular, Inc.

SC11: Liquid Biopsy Technologies and Applications

John Simmons, Ph.D., Director, Translational Science & Diagnostics, Personal Genome Diagnostics

Hatim Husain, M.D., Physician, Medical Oncology, University of California, San Diego

SC12: Leveraging Cloud Technologies to Enable Large-Scale Integration of Human Genome and Clinical Outcomes Data

R. Mark Adams, Ph.D., CIO, Celmatix, Inc.

Anna T. Fernandez, Ph.D., PMP, Senior Associate, Civil Health – Informatics, Booz Allen Hamilton

Andrew FigPope, Data Engineer, Celmatix, Inc.

Sam Globus, Ph.D., Director of Scientific Operations, Celmatix, Inc.

Michael Keller, Ph.D., Senior Associate, Civil Health, Booz Allen Hamilton

Christopher Matta, Systems Engineer, Confluent, Inc.

SC13: Building the Bridge between Science and Commercialization: Leveraging KOLs

Lawrence J. Worden, Principal, IVD Logix

Charles Mathews, Principal, ClearView Healthcare Partners

Peggy Robinson, Vice President, Angle PLC

SC14: Development of Bioassays for Checkpoint Immunotherapy

Richard Somberg, Ph.D., Strategic Collaborations Manager, Promega Corporation

SC15: Microfluidics and Lab-on-a-Chip Devices for POCT: Technologies and Commercialization

Chris Myatt, Founder & CEO, MBio Diagnostics, Inc.

Patrice Allibert, Ph.D., CEO and President, GenePOC

Viktor Shkolnikov, Ph.D., Microfluidics, HP Labs

Marta Fernandez Suarez, Daktari Diagnostics & FIND

Kris Buchanan, CEO, Phase Three Product Development

8:00 – 11:00 AM

SC17: Commercialization Boot Camp: Manual for Success in Molecular Diagnostics

Harry Glorikian, MBA, Healthcare Consultant

Stan Skrzypczak, MBA, Vice President, Corporate Development and Reimbursement, Guardant Health, Inc.

Recommended Course Material: Commercializing Novel IVDs: A Comprehensive Manual for Success

Harry Glorikian, MBA, Healthcare Consultant; Author, Commercializing Novel IVD’s Content

Based on the Commercialization Bootcamp Course and experience, the Commercializing Novel IVDs: A Comprehensive Manual for Success, greatly expands on the fundamental topics everyone in or around the IVD industry needs to know - from product ideation and design to regulation to planning for market entry and reimbursement. For companies just starting out, this book is like having your very own IVD reference manual at your fingertips, providing you with a comprehensive overview to help make the process as smooth as possible. For those of you already in the field, it’s a guide that may help bring you up-to-date on the key trends impacting the industry, evolving regulatory issues, and changes that are impacting the way IVDs are marketed and sold. I have tried to present not just the big picture, but highlight the details that might be critical for success. For more information, visit:

SC18: Next-Generation Sequencing as a Diagnostics Platform>

Karl Voelkerding, M.D., Professor of Pathology, University of Utah School of Medicine

Eric Konnick, M.D., MS, FCAP, Acting Assistant Professor, Associate Director, Genetics and Solid Tumor Laboratory Department of Laboratory Medicine University of Washington

Larissa Furtado, M.D., Medical Director, Molecular Oncology, ARUP Laboratories

SC19: Murine Models for Pre-Clinical Studies in Immuno-Oncology

Michael Brehm, Ph.D., Associate Professor, The Robert and Sandra Glass Term Chair in Diabetes, Diabetes Center of Excellence, Program in Molecular Medicine, University of Massachusetts Medical School

Rosemary J. Akhurst, Ph.D., Professor and Director, Preclinical Therapeutics Core, UCSF Helen Diller Family Comprehensive Cancer Center

Barbara Joyce-Shaikh, Associate Principal Scientist, Merck Research Laboratories

SC20: Best Practices in Personalized and Translational Medicine

Corey Bakalarski, Ph.D., Scientist, Genentech

Shimul Chowdhury, PhD, DABMGG, CGMB, Director, Clinical Laboratory, Rady Children’s Institute for Genomic Medicine

Paul Fretter, Head of Computing Infrastructure for Science (CiS), NBI Partnership Ltd.
Ran Goshen, MD, PhD, Chief Medical Officer, Medial EarlySign

Gavin Stone, Vice President of Marketing, Edico Genome

Paul Trevithick, Director, Business Solutions, EPAM Systems

SC21: NGS for Infectious Disease Diagnostics

Charles Chiu, M.D., Ph.D., Associate Professor of Laboratory Medicine and Medicine, Division of Infectious Diseases at University of California, San Francisco, Director of the UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC), and Associate Director of the UCSF Clinical Microbiology Laboratory

SC22: Cell-Based Biomarkers for Cancer Immunotherapy Discovery and Development

Nathan Standifer, Ph.D., Senior Scientist, Clinical Pharmacology and DMPK, MedImmune

Mark Edinger, Scientific Affairs Director, Flow Cytometry, Q2 Solutions

Iulian Pruteanu-Malinici, Ph.D., Biostatistics, Investigator II, Lab Head, Novartis Institutes for BioMedical Research (NIBR)

SC23: Chromosomal Mosaicism in Humans: Clinical Implications for Preimplantation Genetic Screening, Prenatal Diagnosis and Non-Invasive Prenatal Testing

Brynn Levy, Professor, Pathology & Cell Biology at CUMC; Director, Clinical Cytogenetics Laboratory; Co-Director, Division of Personalized Genomic Medicine, College of Physicians and Surgeons, Columbia University Medical Center, and the New York Presbyterian Hospital

6:00 – 9:00 PM

SC25: Detection and Characterization of Circulating Biomarkers

Catherine Alix-Panabières, Ph.D., Director, Laboratory of Rare Human Circulating Cells (LCCRH), Cellular and Tissular Biopathology of Cancers, University Medical Center of Montpellier

Klaus Pantel, M.D., Professor and Founding Director, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, University of Hamburg

SC26: Multiplexing Single Cell Analysis: A Combined Effort

Junyue Cao, Research Assistant, Jay Shendure Laboratory, Genomic Science, University of Washington

Ryan Mulqueen, Research Scientist, Brian J. O’Roak and Andrew Adey Laboratories, Molecular and Medical Genetics, Oregon Health & Science University

Kristof Torkenczy, Research Scientist, Andrew Adey Laboratory, Department of Molecular and Medical Genetics, Oregon Health & Science University

SC27: CRISPR-Based Gene Editing for Drug Discovery & Targeted Therapies

Clifford Steer, M.D., Professor of Medicine and, Genetics, Cell Biology, and Development; Director, Molecular Gastroenterology Program, University of Minnesota Medical School

Arthur L. Shaffer III, Ph.D., Staff Scientist, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health

Daniel P. Dever, Ph.D., Instructor, Laboratory of Dr. Matthew Porteus, Department of Pediatrics, Division of Stem Cell Transplantation and Regenerative Medicine, Stanford University Medical Center

SC28: Mastering Variant Interpretation

Jeanette McCarthy, MPH, Ph.D., Adjunct Associate Professor, Duke University; Founder, Precision Medicine Advisors

Register Now
March 26-27, 2024

AI in Precision Medicine

Implementing Precision Medicine

At-Home & Point-of-Care Diagnostics

Liquid Biopsy

Spatial Biology

March 27-28, 2024

AI in Diagnostics

Diagnostics Market Access

Infectious Disease Diagnostics

Multi-Cancer Early Detection

Single-Cell Multiomics